These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 10699346

  • 1. Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy.
    Lee NG, Jung SB, Ahn BY, Kim YH, Kim JJ, Kim DK, Kim IS, Yoon SM, Nam SW, Kim HS, Park WJ.
    Vaccine; 2000 Mar 17; 18(18):1952-61. PubMed ID: 10699346
    [Abstract] [Full Text] [Related]

  • 2. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
    Faezi S, Safarloo M, Amirmozafari N, Nikokar I, Siadat SD, Holder IA, Mahdavi M.
    APMIS; 2014 Feb 17; 122(2):115-27. PubMed ID: 23758581
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the immune responses following co-administration of PilQ and type b-flagellin from Pseudomonas aeruginosa in the burn mouse model.
    Bakht Azad S, Nikokar I, Faezi S, Rasooly S, Mahdavi M.
    Microb Pathog; 2018 Oct 17; 123():426-432. PubMed ID: 30075242
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of two immunization schedules for a Pseudomonas aeruginosa outer membrane proteins vaccine in burn patients.
    Kim DK, Kim JJ, Kim JH, Woo YM, Kim S, Yoon DW, Choi CS, Kim I, Park WJ, Lee N, Jung SB, Ahn BY, Nam SW, Yoon SM, Choi WJ.
    Vaccine; 2000 Dec 08; 19(9-10):1274-83. PubMed ID: 11137267
    [Abstract] [Full Text] [Related]

  • 6. Conformation-dependent antibody response to Pseudomonas aeruginosa outer membrane proteins induced by immunization in humans.
    Lee N, Ahn B, Jung SB, Kim YG, Kim H, Park WJ.
    FEMS Immunol Med Microbiol; 2000 Jan 08; 27(1):79-85. PubMed ID: 10617794
    [Abstract] [Full Text] [Related]

  • 7. Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model.
    Matthews-Greer JM, Gilleland HE.
    J Infect Dis; 1987 Jun 08; 155(6):1282-91. PubMed ID: 3033095
    [Abstract] [Full Text] [Related]

  • 8. Human immune response to a Pseudomonas aeruginosa outer membrane protein vaccine.
    Jang IJ, Kim IS, Park WJ, Yoo KS, Yim DS, Kim HK, Shin SG, Chang WH, Lee NG, Jung SB, Ahn DH, Cho YJ, Ahn BY, Lee Y, Kim YG, Nam SW, Kim HS.
    Vaccine; 1999 Jan 08; 17(2):158-68. PubMed ID: 9987150
    [Abstract] [Full Text] [Related]

  • 9. Safety and immunogenicity of an oral inactivated whole-cell pseudomonas aeruginosa vaccine administered to healthy human subjects.
    Cripps AW, Peek K, Dunkley M, Vento K, Marjason JK, McIntyre ME, Sizer P, Croft D, Sedlak-Weinstein L.
    Infect Immun; 2006 Feb 08; 74(2):968-74. PubMed ID: 16428742
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human anti-Pseudomonas aeruginosa outer membrane proteins IgG cross-protective against infection with heterologous immunotype strains of P. aeruginosa.
    Lee NG, Ahn BY, Jung SB, Kim YG, Lee Y, Kim HS, Park WJ.
    FEMS Immunol Med Microbiol; 1999 Sep 08; 25(4):339-47. PubMed ID: 10497864
    [Abstract] [Full Text] [Related]

  • 13. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
    Hassan R, El-Naggar W, Abd El-Aziz AM, Shaaban M, Kenawy HI, Ali YM.
    J Microbiol Immunol Infect; 2018 Jun 08; 51(3):312-320. PubMed ID: 28291719
    [Abstract] [Full Text] [Related]

  • 14. Production and characterization of a human hyperimmune intravenous immunoglobulin against Pseudomonas aeruginosa and Klebsiella species.
    Cryz SJ, Fürer E, Sadoff JC, Fredeking T, Que JU, Cross AS.
    J Infect Dis; 1991 May 08; 163(5):1055-61. PubMed ID: 1902245
    [Abstract] [Full Text] [Related]

  • 15. [Polish preparations for preventing and treating infections caused by Pseudomonas aeruginosa].
    Schiller B, Buchowicz I, Lysakowska E, Sakiel S, Korbecki M.
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr 08; (4):30-2. PubMed ID: 2409720
    [Abstract] [Full Text] [Related]

  • 16. Protective effect of an outer membrane vaccine against Pseudomonas aeruginosa infection.
    von Specht BU, Strigl G, Ehret W, Brendel W.
    Infection; 1987 Apr 08; 15(5):408-12. PubMed ID: 3121520
    [Abstract] [Full Text] [Related]

  • 17. Pseudomonas aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus.
    Brennan FR, Jones TD, Gilleland LB, Bellaby T, Xu F, North PC, Thompson A, Staczek J, Lin T, Johnson JE, Hamilton WDO, Gilleland HE.
    Microbiology (Reading); 1999 Jan 08; 145 ( Pt 1)():211-220. PubMed ID: 10206701
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Flagellin and pilin immunization against multi-drug resistant Pseudomonas aeruginosa protects mice in the burn wound sepsis model.
    Korpi F, Hashemi FB, Irajian G, Fatemi MJ, Laghaei P, Behrouz B.
    Immunol Lett; 2016 Aug 08; 176():8-17. PubMed ID: 27210422
    [Abstract] [Full Text] [Related]

  • 20. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates.
    von Specht B, Knapp B, Hungerer K, Lücking C, Schmitt A, Domdey H.
    J Biotechnol; 1996 Jan 26; 44(1-3):145-53. PubMed ID: 8717398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.